The Nanostring nCounter system is developed for multiplex gene expression analysis of up to 800 gene targets per reaction.
The Nanostring system is suitable for identification of disease specific biomarkers, verifying gene signatures or investigating specific biological pathways.
Nanostring offers a range of panels targeting disease or biological pathways:
- Oncology and Immuno-oncology
- Autoimmune diseases and response
- Immunology, Inflammation and host responses to infection
- Neurobiology and Neuroinflammation
It is also possible to create a custom panel with your genes of interest.
Nanostring has released a panel plus gene panel for studying the SARS-CoV-2 virus and the host response to Covid-19.
For more information about panels and the technology contact us or visit Nanostrings website